Business Description
Akso Health Group
NAICS : 522291
SIC : 6141
ISIN : US4282951098
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 243.35 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 53.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13.8 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -63.9 | |||||
3-Year Book Growth Rate | -3.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.82 | |||||
9-Day RSI | 39.04 | |||||
14-Day RSI | 42.16 | |||||
6-1 Month Momentum % | -28.51 | |||||
12-1 Month Momentum % | -22.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 39.52 | |||||
Quick Ratio | 39.46 | |||||
Cash Ratio | 23.7 | |||||
Days Inventory | 164.7 | |||||
Days Sales Outstanding | 1080.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -107.6 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.05 | |||||
Operating Margin % | -357.68 | |||||
Net Margin % | -391.68 | |||||
FCF Margin % | 55.94 | |||||
ROE % | -18.63 | |||||
ROA % | -15.82 | |||||
ROIC % | -46.2 | |||||
ROC (Joel Greenblatt) % | -17.07 | |||||
ROCE % | -17.87 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 16.22 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 41.84 | |||||
Price-to-Operating-Cash-Flow | 41.84 | |||||
EV-to-EBIT | -33.9 | |||||
EV-to-EBITDA | -33.9 | |||||
EV-to-Revenue | 127.62 | |||||
EV-to-FCF | 228.13 | |||||
Price-to-Projected-FCF | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 0.84 | |||||
Price-to-Net-Cash | 1.42 | |||||
Earnings Yield (Greenblatt) % | -2.95 | |||||
FCF Yield % | 0.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AHG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Akso Health Group Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.415 | ||
EPS (TTM) ($) | -0.191 | ||
Beta | -0.96 | ||
Volatility % | 150.01 | ||
14-Day RSI | 42.16 | ||
14-Day ATR ($) | 0.099232 | ||
20-Day SMA ($) | 0.896783 | ||
12-1 Month Momentum % | -22.22 | ||
52-Week Range ($) | 0.53 - 2.9 | ||
Shares Outstanding (Mil) | 398.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Akso Health Group Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Akso Health Group Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Akso Health Group Frequently Asked Questions
What is Akso Health Group(AHG)'s stock price today?
When is next earnings date of Akso Health Group(AHG)?
Does Akso Health Group(AHG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |